What to know
Flu vaccine is produced by private manufacturers, so supply depends on manufacturers. Vaccine manufacturers have projected that they will supply the United States with as many as 156.2 million to 170 million doses of influenza vaccines for the 2023-2024 season. These projections may change as the season progresses. All flu vaccines for the 2024-2025 season will be trivalent (three component). Most will be thimerosal-free or thimerosal-reduced vaccine (91%), and about 21% of flu vaccines will be egg-free.
Total Doses Distributed
| Week | Total Doses Distributed (in millions) |
|---|---|
| 3/9/2024 | 157.72M |
| 3/2/2024 | 157.62M |
| 2/24/2024 | 157.51M |
| 2/10/2024 | 157.19M |
| 2/3/2024 | 156.96M |
| 1/27/2024 | 156.76M |
| 1/20/2024 | 156.42M |
| 1/13/2024 | 156.26M |
| 12/31/2023 | 155.36M |
| 12/23/2023 | 155.20M |
| 12/9/2023 | 153.62M |
| 12/2/2023 | 152.42M |
| 11/25/2023 | 151.30M |
| 11/18/2023 | 150.63M |
| 11/11/2023 | 148.95M |
| 11/4/2023 | 147.47M |
| 10/28/2023 | 145.42M |
| 10/21/2023 | 142.16M |
| 10/14/2023 | 136.94M |
| 10/7/2023 | 128.35M |
| 9/30/2023 | 116.29M |
| 9/23/2023 | 100.51M |
| 9/16/2023 | 83.59M |
| 9/9/2023 | 68.65M |
| 9/2/2023 | 54.54M |